{"id": "1433725204623081477", "creation": 1630661700.0, "user_id": "1168043884246515712", "social_network": "twitter", "nsfw": false, "request": ["6701c9aa-27fd-4cef-822d-72fe0c43583a"], "metrics": {"6701c9aa-27fd-4cef-822d-72fe0c43583a": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Another indigeneous #COVID19Vaccine candidate #CORBEVAX receives #DCGI approval for two #clinicaltrials. #Vaccine maker #BiologicalE receives approval from DCGI to conduct phase two and three clinical trials on #children aged 5 to 18 years with certain conditions.\n#COVID19 https://t.co/YjPVJGXoEr", "first_save": 1639747523.726789, "hashtags": ["#COVID19VACCINE", "#CORBEVAX", "#DCGI", "#CLINICALTRIALS", "#VACCINE", "#BIOLOGICALE", "#CHILDREN", "#COVID19"]}